Department of Biostatistics
Theodore Karrison has not added Biography.
If you are Theodore Karrison and would like to personalize this page please email our Author Liaison for assistance.
Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial.
The Journal of pharmacology and experimental therapeutics Jan, 2002 | Pubmed ID: 11752106
Sizes of ruptured and unruptured aneurysms in relation to their sites and the ages of patients.
Journal of neurosurgery Jan, 2002 | Pubmed ID: 11794606
Data management and statistical methods used in the analysis of balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and therapy-related acute leukemia: report from an international workshop.
Genes, chromosomes & cancer Apr, 2002 | Pubmed ID: 11921270
Evaluation of the direct antiglobulin (Coombs') test for identifying newborns at risk for hemolysis as determined by end-tidal carbon monoxide concentration (ETCOc); and comparison of the Coombs' test with ETCOc for detecting significant jaundice.
Journal of perinatology : official journal of the California Perinatal Association Jul-Aug, 2002 | Pubmed ID: 12082466
Isoimmunization is unlikely to be the cause of hemolysis in ABO-incompatible but direct antiglobulin test-negative neonates.
Pediatrics Jul, 2002 | Pubmed ID: 12093957
Troxacitabine in patients with refractory leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Aug, 2002 | Pubmed ID: 12149312
Determination of the optimal modulatory dose of O6-benzylguanine in patients with surgically resectable tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research Aug, 2002 | Pubmed ID: 12171878
Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.
Cancer research Nov, 2002 | Pubmed ID: 12438272
Predictors of emergency medical services utilization by elders.
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine Jan, 2003 | Pubmed ID: 12511315
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.
Blood Jul, 2003 | Pubmed ID: 12623843
The aspect ratio (dome/neck) of ruptured and unruptured aneurysms.
Journal of neurosurgery Sep, 2003 | Pubmed ID: 12959428
A group sequential, response-adaptive design for randomized clinical trials.
Controlled clinical trials Oct, 2003 | Pubmed ID: 14500050
Long-term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis: a prospective observational study.
Annals of surgery Sep, 2003 | Pubmed ID: 14501509
Prognostic factors for survival with gemcitabine plus 5-fluorouracil based regimens for metastatic renal cancer.
The Journal of urology Oct, 2003 | Pubmed ID: 14501711
Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage.
Journal of neurosurgery Oct, 2003 | Pubmed ID: 14567598
A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma.
Cancer Jan, 2004 | Pubmed ID: 14692025
Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells.
Cancer research Mar, 2004 | Pubmed ID: 14996737
Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Apr, 2004 | Pubmed ID: 15007088
Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumors.
Oncogene May, 2004 | Pubmed ID: 15077191
9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium.
Investigational new drugs Aug, 2004 | Pubmed ID: 15122080
A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research May, 2004 | Pubmed ID: 15161690
Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial.
Annals of internal medicine Jul, 2004 | Pubmed ID: 15238367
Fetal loss associated with excess thyroid hormone exposure.
JAMA : the journal of the American Medical Association Aug, 2004 | Pubmed ID: 15304465
The human BCL6 transgene promotes the development of lymphomas in the mouse.
Proceedings of the National Academy of Sciences of the United States of America Sep, 2004 | Pubmed ID: 15375218
Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec, 2004 | Pubmed ID: 15570084
Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanine.
Cancer chemotherapy and pharmacology Apr, 2005 | Pubmed ID: 15723259
Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans.
Journal of clinical pharmacology May, 2005 | Pubmed ID: 15831777
Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
Cancer research Apr, 2005 | Pubmed ID: 15833844
Studies in hemolysis in glucose-6-phosphate dehydrogenase-deficient African American neonates.
Clinica chimica acta; international journal of clinical chemistry Mar, 2006 | Pubmed ID: 16188248
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov, 2005 | Pubmed ID: 16258101
Gene expression profiles in acute myeloid leukemia with common translocations using SAGE.
Proceedings of the National Academy of Sciences of the United States of America Jan, 2006 | Pubmed ID: 16418266
A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma.
Investigational new drugs Mar, 2006 | Pubmed ID: 16514482
Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America May, 2006 | Pubmed ID: 16619149
A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer.
Cancer biology & therapy Jul, 2006 | Pubmed ID: 16760642
Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
Pediatrics Aug, 2006 | Pubmed ID: 16864640
Continuous Bayesian adaptive randomization based on event times with covariates by Cheung et al., Statistics in Medicine 2006; 25:55-70.
Statistics in medicine Jul, 2007 | Pubmed ID: 17163577
Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant.
American journal of clinical pathology Feb, 2007 | Pubmed ID: 17210514
Testing the wrong hypothesis in phase II oncology trials: there is a better alternative.
Clinical cancer research : an official journal of the American Association for Cancer Research Feb, 2007 | Pubmed ID: 17289865
A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma.
Cancer biology & therapy Apr, 2007 | Pubmed ID: 17457044
Whole blood viscosity and arterial thrombotic events in patients with systemic lupus erythematosus.
Arthritis and rheumatism Jun, 2007 | Pubmed ID: 17530685
Safety and tolerability of Ganoderma lucidum in healthy subjects: a double-blind randomized placebo-controlled trial.
The American journal of Chinese medicine , 2007 | Pubmed ID: 17597499
Critical evaluation of diagnostic aids for the detection of oral cancer.
Oral oncology Jan, 2008 | Pubmed ID: 17825602
Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.
Journal of the National Cancer Institute Oct, 2007 | Pubmed ID: 17895472
Reproducibility and sources of variability in radiographic texture analysis of densitometric calcaneal images.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry Apr-Jun, 2008 | Pubmed ID: 18158263
Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia.
Investigational new drugs Jun, 2008 | Pubmed ID: 18217206
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.
Leukemia & lymphoma Mar, 2008 | Pubmed ID: 18297531
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Mar, 2008 | Pubmed ID: 18309947
IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers.
The Journal of clinical investigation Apr, 2008 | Pubmed ID: 18317595
A phase I and pharmacokinetic study of the quinoxaline antitumour Agent R(+)XK469 in patients with advanced solid tumours.
European journal of cancer (Oxford, England : 1990) Aug, 2008 | Pubmed ID: 18650079
Modeling major lung resection outcomes using classification trees and multiple imputation techniques.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery Nov, 2008 | Pubmed ID: 18760930
Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct, 2008 | Pubmed ID: 18824708
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
The lancet oncology Mar, 2009 | Pubmed ID: 19201650
A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research Feb, 2009 | Pubmed ID: 19228743
A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.
European urology Jul, 2009 | Pubmed ID: 19282098
Design of Phase II cancer trials for evaluation of cytostatic/cytotoxic agents.
Journal of biopharmaceutical statistics , 2009 | Pubmed ID: 19384693
What does it cost physician practices to interact with health insurance plans?
Health affairs (Project Hope) Jul-Aug, 2009 | Pubmed ID: 19443477
Frequency of failure to inform patients of clinically significant outpatient test results.
Archives of internal medicine Jun, 2009 | Pubmed ID: 19546413
Phase II study of sunitinib malate in head and neck squamous cell carcinoma.
Investigational new drugs Oct, 2010 | Pubmed ID: 19649772
Common fragile sites are characterized by histone hypoacetylation.
Human molecular genetics Dec, 2009 | Pubmed ID: 19717471
Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research Oct, 2009 | Pubmed ID: 19773379
Impaired replication dynamics at the FRA3B common fragile site.
Human molecular genetics Jan, 2010 | Pubmed ID: 19815620
Neoplasms with schwannian differentiation express transcription factors known to regulate normal schwann cell development.
International journal of surgical pathology Dec, 2010 | Pubmed ID: 20034979
CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases.
PloS one , 2010 | Pubmed ID: 20126411
A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma.
American journal of clinical oncology Apr, 2011 | Pubmed ID: 20395787
Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jun, 2010 | Pubmed ID: 20421534
Outcomes in black patients with early breast cancer treated with breast conservation therapy.
International journal of radiation oncology, biology, physics Feb, 2011 | Pubmed ID: 20434849
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov, 2010 | Pubmed ID: 20837940
A phase I study of continuous infusion cilengitide in patients with solid tumors.
Investigational new drugs Apr, 2012 | Pubmed ID: 20839028
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.
Cancer biology & therapy Jul, 2011 | Pubmed ID: 21543897
Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database.
Journal of clinical bioinformatics Feb, 2011 | Pubmed ID: 21603121
The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patients.
Cancer chemotherapy and pharmacology Dec, 2011 | Pubmed ID: 21861128
Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Dec, 2011 | Pubmed ID: 22021924
Targeted and Cytotoxic Therapy in Coordinated Sequence (TACTICS): Erlotinib, Bevacizumab, and Standard Chemotherapy for Non-Small-Cell Lung Cancer, A Phase II Trial.
Clinical lung cancer Nov, 2011 | Pubmed ID: 22100149
MET and phosphorylated MET as potential biomarkers in lung cancer.
Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer , 2011 | Pubmed ID: 22181983
Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity.
Obstetrics and gynecology Jan, 2012 | Pubmed ID: 22183212
Resampling phase III data to assess phase II trial designs and endpoints.
Clinical cancer research : an official journal of the American Association for Cancer Research Jan, 2012 | Pubmed ID: 22287601
Mosmi Surati1,
Matthew Robinson2,
Suvobroto Nandi2,
Leonardo Faoro2,
Carley Demchuk2,
Rajani Kanteti2,
Benjamin Ferguson1,
Tara Gangadhar2,
Thomas Hensing3,
Rifat Hasina2,
Aliya Husain4,
Mark Ferguson5,
Theodore Karrison6,
Ravi Salgia2
1Pritzker School of Medicine, University of Chicago,
2Department of Medicine, University of Chicago,
3Department of Medicine, Northshore University Health Systems,
4Department of Pathology, University of Chicago,
5Department of Surgery, University of Chicago,
6Department of Biostatistics, University of Chicago